Takeda, Wave Life Sciences revise their $230M R&D collaboration, dropping discovery work

Three years after Takeda paid a hefty down payment on a research collab with Wave Life Sciences, the two partners have revised the pact.

The Cambridge biotech announced a revision to its deal with Takeda yesterday — ending their alliance on discovery work. As part of the amendment, Takeda will pay Wave more than $22 million for research and preclinical expenses from the collaboration.